HDAC9 and myocardial infarction: Other HDAC inhibitors such as valproic acid, tributyl butyrate, and vorinostat (or suberoylanilide hydroxamic acid, SAHA) also showed efficacy in attenuating myocardial infarction size and ventricular remodeling by inhibition of HDAC along with inducing an increased angiogenic response [125,126,127].